SGMT - Sagimet Biosciences Inc. Series A -  [ ]

Ticker Details
Sagimet Biosciences Inc. Series A
IPO Date: July 14, 2023
Sector: Healthcare
Industry: Biotech
Market Cap: $453.88M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.32 | 5.31%
Avg Daily Range (30 D): $0.21 | 2.91%
Avg Daily Range (90 D): $0.25 | 4.00%
Institutional Daily Volume
Avg Daily Volume: .83M
Avg Daily Volume (30 D): .79M
Avg Daily Volume (90 D): 1.18M
Trade Size
Avg Trade Size (Sh.): 121
Avg Trade Size (Sh.) (30 D): 80
Avg Trade Size (Sh.) (90 D): 96
Institutional Trades
Total Institutional Trades: 108
Avg Institutional Trade: $1.87M
Avg Institutional Trade (30 D): $3.34M
Avg Institutional Trade (90 D): $2.81M
Avg Institutional Trade Volume: .28M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.17M
Avg Closing Trade (30 D): $4.27M
Avg Closing Trade (90 D): $3.66M
Avg Closing Volume: 477.57K
 
News
Jun 29, 2026 @ 11:00 AM
Sagimet Biosciences Joins the Russell 2000® and...
Source: Na
Jun 23, 2026 @ 12:49 AM
Sagimet Biosciences Announces Participation in Upc...
Source: Na
Apr 20, 2026 @ 11:00 AM
Sagimet Biosciences Announces Appointment of Andre...
Source: Na
Apr 6, 2026 @ 11:00 AM
Sagimet Biosciences Announces Poster and Oral Pres...
Source: Na
Feb 5, 2026 @ 12:00 PM
Sagimet Biosciences Announces Participation in Two...
Source: Na
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-1.35 $-.33 $-.3
Diluted EPS $-1.35 $-.33 $-.3
Revenue $M $M $M
Gross Profit
Net Income / Loss $-43.51M $-10.65M $-9.57M
Operating Income / Loss $-48.74M $-11.71M $-10.77M
Cost of Revenue
Net Cash Flow $-40.82M $M $2.53M
PE Ratio